Diagnosis and treatment of orthostatic hypotension
- PMID: 35841911
- PMCID: PMC10024337
- DOI: 10.1016/S1474-4422(22)00169-7
Diagnosis and treatment of orthostatic hypotension
Abstract
Orthostatic hypotension is an unusually large decrease in blood pressure on standing that increases the risk of adverse outcomes even when asymptomatic. Improvements in haemodynamic profiling with continuous blood pressure measurements have uncovered four major subtypes: initial orthostatic hypotension, delayed blood pressure recovery, classic orthostatic hypotension, and delayed orthostatic hypotension. Clinical presentations are varied and range from cognitive slowing with hypotensive unawareness or unexplained falls to classic presyncope and syncope. Establishing whether symptoms are due to orthostatic hypotension requires careful history taking, a thorough physical examination, and supine and upright blood pressure measurements. Management and prognosis vary according to the underlying cause, with the main distinction being whether orthostatic hypotension is neurogenic or non-neurogenic. Neurogenic orthostatic hypotension might be the earliest clinical manifestation of Parkinson's disease or related synucleinopathies, and often coincides with supine hypertension. The emerging variety of clinical presentations advocates a stepwise, individualised, and primarily non-pharmacological approach to the management of orthostatic hypotension. Such an approach could include the cessation of blood pressure lowering drugs, adoption of lifestyle measures (eg, counterpressure manoeuvres), and treatment with pharmacological agents in selected cases.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests HK is supported by grants from the Familial Dysautonomia Foundation, the Michael J Fox Foundation for Parkinson's Research, the Multiple System Atrophy Coalition, the National Institutes of Health (NIH; R01HL103988 and U54NS065736), and the US Food and Drug Administration (FDR3731–01); receives royalties from Up to Date; receives consultancy and speakers’ fees from Med-IQ, Biogen, Biohaven Pharmaceuticals, Lundbeck, Pfizer, and Theravance Biopharma; and serves as the editor-in-chief of Clinical Autonomic Research. VEC is supported by grants from the Canadian Institutes of Health Research, the National Sciences and Engineering Research Council of Canada, the International Collaboration on Repair Discoveries, the Heart and Stroke Foundation of Canada, and the Craig H Neilsen Foundation. SPJ is supported by NIH grants K23HL135273 and R56HL153191. RDT reports consultancy and speakers’ fees from Union Chimique Belge, GlaxoSmithKline, Theravance, Novartis, and Zogenix; and grants from the Dutch National Epilepsy Fund, the Michael J Fox Foundation for Parkinson's Research (MJFF-020200), Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie, Medtronic, New Life Wearables, and The Netherlands Organisation for Health Research and Development (114025101). All other authors declare no competing interests.
Figures




Similar articles
-
Management of Orthostatic Hypotension in Parkinson's Disease.J Parkinsons Dis. 2020;10(s1):S57-S64. doi: 10.3233/JPD-202036. J Parkinsons Dis. 2020. PMID: 32716319 Free PMC article. Review.
-
[Orthostatic hypotension and supine hypertension: a practical guide to diagnosis and management].G Ital Cardiol (Rome). 2021 Jan;22(1):42-52. doi: 10.1714/3502.34882. G Ital Cardiol (Rome). 2021. PMID: 33470242 Review. Italian.
-
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.Lancet Neurol. 2016 Aug;15(9):954-966. doi: 10.1016/S1474-4422(16)30079-5. Lancet Neurol. 2016. PMID: 27478953 Review.
-
Diagnosing and treating neurogenic orthostatic hypotension in primary care.Postgrad Med. 2015;127(7):702-15. doi: 10.1080/00325481.2015.1050340. Epub 2015 May 27. Postgrad Med. 2015. PMID: 26012731 Review.
-
Current concepts in orthostatic hypotension management.Curr Hypertens Rep. 2013 Aug;15(4):304-12. doi: 10.1007/s11906-013-0362-3. Curr Hypertens Rep. 2013. PMID: 23832761 Free PMC article. Review.
Cited by
-
Haemodynamic Parameters Underlying the Relationship between Sarcopenia and Blood Pressure Recovery on Standing.J Clin Med. 2023 Dec 19;13(1):18. doi: 10.3390/jcm13010018. J Clin Med. 2023. PMID: 38202023 Free PMC article.
-
Recent updates in autonomic research: new insights into vagal nerve activity during exercise, cardiac autonomic neuropathy and silent myocardial infarction in diabetes, and timing of orthostatic blood pressure change and future risk of dementia.Clin Auton Res. 2023 Dec;33(6):619-621. doi: 10.1007/s10286-023-00999-x. Epub 2023 Nov 4. Clin Auton Res. 2023. PMID: 37924394 No abstract available.
-
Aetiology and haemodynamic patterns of orthostatic hypotension in a tertiary syncope unit.Europace. 2025 May 7;27(5):euaf017. doi: 10.1093/europace/euaf017. Europace. 2025. PMID: 39821313 Free PMC article.
-
Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial.Contemp Clin Trials Commun. 2024 Jul 28;41:101339. doi: 10.1016/j.conctc.2024.101339. eCollection 2024 Oct. Contemp Clin Trials Commun. 2024. PMID: 39176240 Free PMC article.
-
Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians.J Neural Transm (Vienna). 2024 Oct;131(10):1263-1273. doi: 10.1007/s00702-024-02838-3. Epub 2024 Oct 7. J Neural Transm (Vienna). 2024. PMID: 39370478 Review.
References
-
- Mol A, Bui Hoang PTS, Sharmin S, et al. Orthostatic hypotension and falls in older adults: a systematic review and meta-analysis. J Am Med Dir Assoc 2019; 20: 589–97.e5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical